Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2018

Publisher Name :
Date: 12-Jun-2018
No. of pages: 188
Inquire Before Buying

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2018

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2018, provides an overview of the Retinitis Pigmentosa (Retinitis) (Ophthalmology) pipeline landscape.

Retinitis Pigmentosa (RP) refers to a group of diseases which cause a slow but progressive vision loss. Retinitis pigmentosa is caused by a genetic defect. Symptoms include night blindness and loss of peripheral vision. The predisposing factors include autosomal dominant inheritance, autosomal recessive inheritance and x-linked inheritance.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Retinitis Pigmentosa (Retinitis) (Ophthalmology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Retinitis Pigmentosa (Retinitis) (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Retinitis Pigmentosa (Retinitis) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 2, 12, 3, 31 and 7 respectively. Similarly, the Universities portfolio in Phase I and Preclinical stages comprises 1 and 11 molecules, respectively.

Retinitis Pigmentosa (Retinitis) (Ophthalmology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Retinitis Pigmentosa (Retinitis) (Ophthalmology).

- The pipeline guide reviews pipeline therapeutics for Retinitis Pigmentosa (Retinitis) (Ophthalmology) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Retinitis Pigmentosa (Retinitis) (Ophthalmology) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Retinitis Pigmentosa (Retinitis) (Ophthalmology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Retinitis Pigmentosa (Retinitis) (Ophthalmology)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Retinitis Pigmentosa (Retinitis) (Ophthalmology).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Retinitis Pigmentosa (Retinitis) (Ophthalmology) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2018

Table of Contents
Table of Contents 2
Introduction 5
Retinitis Pigmentosa (Retinitis) - Overview 6
Retinitis Pigmentosa (Retinitis) - Therapeutics Development 7
Retinitis Pigmentosa (Retinitis) - Therapeutics Assessment 18
Retinitis Pigmentosa (Retinitis) - Companies Involved in Therapeutics Development 26
Retinitis Pigmentosa (Retinitis) - Drug Profiles 40
Retinitis Pigmentosa (Retinitis) - Dormant Projects 162
Retinitis Pigmentosa (Retinitis) - Discontinued Products 164
Retinitis Pigmentosa (Retinitis) - Product Development Milestones 165
Appendix 180

List of Tables
Number of Products under Development for Retinitis Pigmentosa (Retinitis), H1 2018
Number of Products under Development by Companies, H1 2018
Number of Products under Development by Companies, H1 2018 (Contd..1), H1 2018
Number of Products under Development by Companies, H1 2018 (Contd..2), H1 2018
Number of Products under Development by Universities/Institutes, H1 2018
Products under Development by Companies, H1 2018
Products under Development by Companies, H1 2018 (Contd..1), H1 2018
Products under Development by Companies, H1 2018 (Contd..2), H1 2018
Products under Development by Companies, H1 2018 (Contd..3), H1 2018
Products under Development by Universities/Institutes, H1 2018
Number of Products by Stage and Target, H1 2018
Number of Products by Stage and Mechanism of Action, H1 2018
Number of Products by Stage and Route of Administration, H1 2018
Number of Products by Stage and Molecule Type, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Acucela Inc, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Allergan Plc, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Amarantus Bioscience Holdings Inc, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Amgen Inc, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Applied Genetic Technologies Corp, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Astellas Pharma Inc, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Dompe Farmaceutici SpA, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by EyePoint Pharmaceuticals Inc, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Eyevensys SAS, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by GenSight Biologics SA, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Grupo Ferrer Internacional SA, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Horama SA, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by ID Pharma Co Ltd, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by InFlectis BioScience, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Ionis Pharmaceuticals Inc, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by M's Science Corp, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by MimeTech Srl, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Miragen Therapeutics Inc, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Nanovector srl, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Novartis AG, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Novelion Therapeutics Inc, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Profarma, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by ProQR Therapeutics NV, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Recursion Pharmaceuticals Inc, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by ReNeuron Group Plc, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by SanBio Inc, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Sanofi, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Spark Therapeutics Inc, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Sumitomo Dainippon Pharma Co Ltd, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Sun Pharma Advanced Research Company Ltd, H1 2018
Retinitis Pigmentosa (Retinitis) - Dormant Projects, H1 2018
Retinitis Pigmentosa (Retinitis) - Dormant Projects, H1 2018 (Contd..1), H1 2018
Retinitis Pigmentosa (Retinitis) - Discontinued Products, H1 2018

List of Figures
Number of Products under Development for Retinitis Pigmentosa (Retinitis), H1 2018
Number of Products under Development by Companies, H1 2018
Number of Products under Development by Universities/Institutes, H1 2018
Number of Products by Top 10 Targets, H1 2018
Number of Products by Stage and Top 10 Targets, H1 2018
Number of Products by Top 10 Mechanism of Actions, H1 2018
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2018
Number of Products by Routes of Administration, H1 2018
Number of Products by Stage and Top 10 Routes of Administration, H1 2018
Number of Products by Molecule Types, H1 2018
Number of Products by Stage and Molecule Types, H1 2018
  • Global Indoleamine 2,3 Dioxygenase 1 Market Insights, Forecast to 2025
    Published: 07-Dec-2018        Price: US 3900 Onwards        Pages: 119
    In 2017, the global Indoleamine 2,3 Dioxygenase 1 market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Indoleamine 2,3 Dioxygenase 1 market based on company, product type, application and key regions. This report studies the global market size of Indoleamine 2,3 Dioxygenase 1 in key regions like North America, Europe, Asia Pacific, Central & South America ......
  • Global Integrin Beta 1 Market Insights, Forecast to 2025
    Published: 07-Dec-2018        Price: US 3900 Onwards        Pages: 113
    In 2017, the global Integrin Beta 1 market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Integrin Beta 1 market based on company, product type, application and key regions. This report studies the global market size of Integrin Beta 1 in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the c......
  • Global and Chinese Perphenazines Industry, 2018 Market Research Report
    Published: 07-Dec-2018        Price: US 3000 Onwards        Pages: 146
    The 'Global and Chinese Perphenazines Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Perphenazines industry with a focus on the Chinese market. The report provides key statistics on the market status of the Perphenazines manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its definition,......
  • Global High Affinity Nerve Growth Factor Receptor Market Insights, Forecast to 2025
    Published: 07-Dec-2018        Price: US 3900 Onwards        Pages: 125
    In 2017, the global High Affinity Nerve Growth Factor Receptor market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the High Affinity Nerve Growth Factor Receptor market based on company, product type, application and key regions. This report studies the global market size of High Affinity Nerve Growth Factor Receptor in key regions like North America, Europe,......
  • Global Fanconi Anemia Drug Market Insights, Forecast to 2025
    Published: 07-Dec-2018        Price: US 3900 Onwards        Pages: 113
    In 2017, the global Fanconi Anemia Drug market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Fanconi Anemia Drug market based on company, product type, application and key regions. This report studies the global market size of Fanconi Anemia Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focu......
  • Global and Chinese 7-Aminocephalosporanic acid (7-ACA) Industry, 2018 Market Research Report
    Published: 07-Dec-2018        Price: US 3000 Onwards        Pages: 135
    The 'Global and Chinese 7-Aminocephalosporanic Acid (7-ACA) Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global 7-Aminocephalosporanic Acid (7-ACA) industry with a focus on the Chinese market. The report provides key statistics on the market status of the 7-Aminocephalosporanic Acid (7-ACA) manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report p......
  • Global Systemic Idiopathic Juvenile Arthritis Treatment Market Insights, Forecast to 2025
    Published: 07-Dec-2018        Price: US 3900 Onwards        Pages: 110
    In 2017, the global Systemic Idiopathic Juvenile Arthritis Treatment market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Systemic Idiopathic Juvenile Arthritis Treatment market based on company, product type, application and key regions. This report studies the global market size of Systemic Idiopathic Juvenile Arthritis Treatment in key regions like Nort......
  • Global Pseudomonas Aeruginosa Pneumonia Drug Market Insights, Forecast to 2025
    Published: 07-Dec-2018        Price: US 3900 Onwards        Pages: 118
    In 2017, the global Pseudomonas Aeruginosa Pneumonia Drug market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Pseudomonas Aeruginosa Pneumonia Drug market based on company, product type, application and key regions. This report studies the global market size of Pseudomonas Aeruginosa Pneumonia Drug in key regions like North America, Europe, Asia Pacific, ......
  • Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market Insights, Forecast to 2025
    Published: 07-Dec-2018        Price: US 3900 Onwards        Pages: 110
    In 2017, the global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market based on company, product type, application and key regions. This report studies the global market size of Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 in key regions like Nort......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs